Skip Navigation LinksHome > September 2014 - Volume 26 - Issue 5 > Indications, techniques and outcomes for pelvic exenteration...
Current Opinion in Oncology:
doi: 10.1097/CCO.0000000000000109
GYNECOLOGIC CANCER: Edited by Martin Gore

Indications, techniques and outcomes for pelvic exenteration in gynecological malignancy

Kaur, Manpreeta; Joniau, Stevenb; D’Hoore, Andréc; Vergote, Ignacea

Collapse Box

Abstract

Purpose of review

To review recently published literature presenting an overview of the current insights and (clinical and technical) developments on pelvic exenterative surgery for gynecological malignancies.

Recent findings

Lateral recurrences, positive pelvic node status, age and high body mass index should be abandoned as contraindications for pelvic exenteration. F-fluorodeoxyglucose positron emission tomography-computed tomography is a valuable imaging tool, especially for the detection of enlarged lymph nodes and for distinguishing fibrosis from recurrence. Combined omental plus vertical rectus abdominis myocutaenous flaps give significant reduction in complications, whereas fascia sparing (myo)cutaneous flaps seem promising in decreasing donor-site complications.

Summary

Pelvic exenteration is indicated when curative alternatives are inferior or exhausted for advanced primary or locally gynecological recurrent cancer confined to the pelvis. Palliative pelvic exenteration should only be considered when disease-related morbidity is uncontrollable with other therapeutic modalities. Modifications in different surgical steps are still evolving to decrease the pelvic exenteration associated high morbidity. A complete resection and lymph node invasion free status are directly related to a better prognosis.

© 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins

Login

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.